Loading chat...
ME LD1018
Bill
AI Summary
-
Prohibits pharmaceutical manufacturers from denying, restricting, or interfering with the acquisition or delivery of 340B discounted drugs to 340B entities and their contract pharmacies
-
Bars health insurers, pharmacy benefits managers, and third-party payors from reimbursing 340B entities at lower rates than non-340B pharmacies or imposing different fees, clawbacks, dispensing fees, or network participation requirements
-
Prevents insurers and PBMs from requiring 340B entities to identify drugs as 340B-purchased on claims, submit pricing data, or undergo additional audits not required of other pharmacies
-
Protects patient choice by prohibiting discrimination that interferes with patients receiving 340B drugs from their chosen 340B provider, including via mail or direct delivery
-
Violations are enforceable under the Maine Unfair Trade Practices Act, and 340B entities may bring civil actions in Superior Court; MaineCare is exempt from these provisions
Legislative Description
An Act to Protect Health Care for Rural and Underserved Areas by Prohibiting Discrimination by Participants in a Federal Drug Discount Program
Prescription Drugs
Last Action
Died in Possession of the Senate when the Legislature adjourned Sine Die and was PLACED IN THE LEGISLATIVE FILES. (DEAD)
6/25/2025